MCP-2→Niacinamide→Peptide Fragments→poly-ADP-ribose

• 15826819(MCP-2): Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

  Repertaxin (15 mg/kg) was administered systemically at the time of ischemia and every 2 h for four times.

• 12419488(Niacinamide): The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats.

  Nicotinamide is known to inhibit poly (ADP-ribose) polymerase at early time points , but was found to increase poly (ADP-ribose) polymerase activity at 24 h of reperfusion.

• 8755499(Peptide Fragments): Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

  The crystal structures of the catalytic fragment of chicken poly (ADP-ribose) polymerase (NAD + ADP-ribosyltransferase ; NAD + : poly (adenosine-diphosphate-D-ribosyl) - acceptor ADP-D-ribosyltransferase , EC 2.4.2.30) with and without a nicotinamide-analogue inhibitor have been elucidated.

• 10504727(poly-ADP-ribose): Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.

  The crystal structure of the kinetically trapped VIP2-NAD complex identifies the NAD binding cleft within the C-terminal enzymatic domain and provides a structural basis for understanding the targeting and catalysis of the medically and environmentally important binary toxins.